Putnam BioRevolution ETF ASND Holdings History
Putnam BioRevolution ETF's Ascendis Pharma AS Holding Summary
As of 2025-04-30, Putnam ETF Trust held 1,267.00 shares of Ascendis Pharma AS(ASND), totaling $215,950.00. This investment constitutes 4.53% of their stock portfolio, and Putnam ETF Trust now holds 0% of the outstanding Ascendis Pharma AS(ASND) stock.
The initial trade took place in 2022Q4. And since then Putnam BioRevolution ETF has made 4 purchases of ASND, at an average price of $105.28, for a total of 1,477.00 shares. In addition, there have been 1 sales at an average price of $150.19 for 210.00 shares. Based on historical transaction data and ASND's current price of $169.90, Putnam BioRevolution ETF's estimated gain on his ASND holdings is $91,298.53, reflecting a 58.71% gain to date.
Putnam BioRevolution ETF ASND ($169.90) Holding Chart
Putnam BioRevolution ETF ASND ($169.90) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
